Cohance Lifesciences Ltd.

NSE: COHANCE | BSE: 543064 | ISIN: INE03QK01018 | Industry: Pharmaceuticals
| Expensive Underperformer
447.9500 -9.45 (-2.07%)
NSE Jan 13, 2026 15:31 PM
Volume: 1.1M
 

logo
Cohance Lifesciences Ltd.
10 May 2022
447.95
-2.07%
buy
by ICICI Direct
Target: 555
ICICI Direct
 
Institutional Investors have increased holdings from 18.64% to 27.33% in Sep 2025 qtr.
More from Cohance Lifesciences Ltd.
Recommended
Market closes lower, dragged down by foreign investor outflows and mixed earnings
Trendlyne Marketwatch | 13 Jan 2026, 04:07PM
IPO wave continues as Amagi Media and Five SMEs open for subscription
| 12 Jan 2026
Five Interesting Stocks Today - January 9, 2026
The Baseline | 09 Jan 2026